Literature DB >> 32835424

YAP and TAZ Promote Periosteal Osteoblast Precursor Expansion and Differentiation for Fracture Repair.

Christopher D Kegelman1,2, Madhura P Nijsure1,2, Yasaman Moharrer1,2, Hope B Pearson3, James H Dawahare3, Kelsey M Jordan1,2, Ling Qin1, Joel D Boerckel1,2.   

Abstract

In response to bone fracture, periosteal progenitor cells proliferate, expand, and differentiate to form cartilage and bone in the fracture callus. These cellular functions require the coordinated activation of multiple transcriptional programs, and the transcriptional regulators Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) regulate osteochondroprogenitor activation during endochondral bone development. However, recent observations raise important distinctions between the signaling mechanisms used to control bone morphogenesis and repair. Here, we tested the hypothesis that YAP and TAZ regulate osteochondroprogenitor activation during endochondral bone fracture healing in mice. Constitutive YAP and/or TAZ deletion from Osterix-expressing cells impaired both cartilage callus formation and subsequent mineralization. However, this could be explained either by direct defects in osteochondroprogenitor differentiation after fracture or by developmental deficiencies in the progenitor cell pool before fracture. Consistent with the second possibility, we found that developmental YAP/TAZ deletion produced long bones with impaired periosteal thickness and cellularity. Therefore, to remove the contributions of developmental history, we next generated adult onset-inducible knockout mice (using Osx-CretetOff ) in which YAP and TAZ were deleted before fracture but after normal development. Adult onset-induced YAP/TAZ deletion had no effect on cartilaginous callus formation but impaired bone formation at 14 days post-fracture (dpf). Earlier, at 4 dpf, adult onset-induced YAP/TAZ deletion impaired the proliferation and expansion of osteoblast precursor cells located in the shoulder of the callus. Further, activated periosteal cells isolated from this region at 4 dpf exhibited impaired osteogenic differentiation in vitro upon YAP/TAZ deletion. Finally, confirming the effects on osteoblast function in vivo, adult onset-induced YAP/TAZ deletion impaired bone formation in the callus shoulder at 7 dpf before the initiation of endochondral ossification. Together, these data show that YAP and TAZ promote the expansion and differentiation of periosteal osteoblast precursors to accelerate bone fracture healing.
© 2020 American Society for Bone and Mineral Research (ASBMR). © 2020 American Society for Bone and Mineral Research (ASBMR).

Entities:  

Keywords:  FRACTURE HEALING; GENETIC ANIMAL MODELS; OSTEOBLASTS; TRANSCRIPTION FACTORS

Year:  2020        PMID: 32835424      PMCID: PMC7988482          DOI: 10.1002/jbmr.4166

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  62 in total

1.  Alternative Wnt Signaling Activates YAP/TAZ.

Authors:  Hyun Woo Park; Young Chul Kim; Bo Yu; Toshiro Moroishi; Jung-Soon Mo; Steven W Plouffe; Zhipeng Meng; Kimberly C Lin; Fa-Xing Yu; Caroline M Alexander; Cun-Yu Wang; Kun-Liang Guan
Journal:  Cell       Date:  2015-08-13       Impact factor: 41.582

Review 2.  A novel transgenic mouse model to study the osteoblast lineage in vivo.

Authors:  Christa Maes; Tatsuya Kobayashi; Henry M Kronenberg
Journal:  Ann N Y Acad Sci       Date:  2007-11       Impact factor: 5.691

3.  The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation.

Authors:  Jinhu Xiong; Maria Almeida; Charles A O'Brien
Journal:  Bone       Date:  2018-04-04       Impact factor: 4.398

4.  Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient.

Authors:  S P Robinson; S M Langan-Fahey; D A Johnson; V C Jordan
Journal:  Drug Metab Dispos       Date:  1991 Jan-Feb       Impact factor: 3.922

5.  Role of YAP/TAZ in mechanotransduction.

Authors:  Sirio Dupont; Leonardo Morsut; Mariaceleste Aragona; Elena Enzo; Stefano Giulitti; Michelangelo Cordenonsi; Francesca Zanconato; Jimmy Le Digabel; Mattia Forcato; Silvio Bicciato; Nicola Elvassore; Stefano Piccolo
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

6.  Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential.

Authors:  Daniel L Worthley; Michael Churchill; Jocelyn T Compton; Yagnesh Tailor; Meenakshi Rao; Yiling Si; Daniel Levin; Matthew G Schwartz; Aysu Uygur; Yoku Hayakawa; Stefanie Gross; Bernhard W Renz; Wanda Setlik; Ashley N Martinez; Xiaowei Chen; Saqib Nizami; Heon Goo Lee; H Paco Kang; Jon-Michael Caldwell; Samuel Asfaha; C Benedikt Westphalen; Trevor Graham; Guangchun Jin; Karan Nagar; Hongshan Wang; Mazen A Kheirbek; Alka Kolhe; Jared Carpenter; Mark Glaire; Abhinav Nair; Simon Renders; Nicholas Manieri; Sureshkumar Muthupalani; James G Fox; Maximilian Reichert; Andrew S Giraud; Robert F Schwabe; Jean-Phillipe Pradere; Katherine Walton; Ajay Prakash; Deborah Gumucio; Anil K Rustgi; Thaddeus S Stappenbeck; Richard A Friedman; Michael D Gershon; Peter Sims; Tracy Grikscheit; Francis Y Lee; Gerard Karsenty; Siddhartha Mukherjee; Timothy C Wang
Journal:  Cell       Date:  2015-01-15       Impact factor: 41.582

7.  Tetracycline labeling of bone in vivo.

Authors:  C S Tam; W Anderson
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

8.  Osterix regulates calcification and degradation of chondrogenic matrices through matrix metalloproteinase 13 (MMP13) expression in association with transcription factor Runx2 during endochondral ossification.

Authors:  Riko Nishimura; Makoto Wakabayashi; Kenji Hata; Takuma Matsubara; Shiho Honma; Satoshi Wakisaka; Hiroshi Kiyonari; Go Shioi; Akira Yamaguchi; Noriyuki Tsumaki; Haruhiko Akiyama; Toshiyuki Yoneda
Journal:  J Biol Chem       Date:  2012-08-06       Impact factor: 5.157

9.  Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow.

Authors:  Satoru Morikawa; Yo Mabuchi; Yoshiaki Kubota; Yasuo Nagai; Kunimichi Niibe; Emi Hiratsu; Sadafumi Suzuki; Chikako Miyauchi-Hara; Narihito Nagoshi; Takehiko Sunabori; Shigeto Shimmura; Atsushi Miyawaki; Taneaki Nakagawa; Toshio Suda; Hideyuki Okano; Yumi Matsuzaki
Journal:  J Exp Med       Date:  2009-10-19       Impact factor: 14.307

Review 10.  Origin of Reparative Stem Cells in Fracture Healing.

Authors:  Beth C Bragdon; Chelsea S Bahney
Journal:  Curr Osteoporos Rep       Date:  2018-08       Impact factor: 5.096

View more
  6 in total

Review 1.  Gone Caving: Roles of the Transcriptional Regulators YAP and TAZ in Skeletal Development.

Authors:  Christopher D Kegelman; Joseph M Collins; Madhura P Nijsure; Emily A Eastburn; Joel D Boerckel
Journal:  Curr Osteoporos Rep       Date:  2020-10       Impact factor: 5.096

2.  Drug repositioning of polaprezinc for bone fracture healing.

Authors:  Eun Ae Ko; Yoo Jung Park; Dong Suk Yoon; Kyoung-Mi Lee; Jihyun Kim; Sujin Jung; Jin Woo Lee; Kwang Hwan Park
Journal:  Commun Biol       Date:  2022-05-16

3.  Effects of chondrogenic priming duration on mechanoregulation of engineered cartilage.

Authors:  Anna M McDermott; Emily A Eastburn; Daniel J Kelly; Joel D Boerckel
Journal:  J Biomech       Date:  2021-06-17       Impact factor: 2.789

4.  Reprogramming bone progenitor identity and potency through control of collagen density and oxygen tension.

Authors:  Rawiya Al Hosni; Laurent Bozec; Scott J Roberts; Umber Cheema
Journal:  iScience       Date:  2022-03-11

5.  Mechanosensitive Piezo1 is crucial for periosteal stem cell-mediated fracture healing.

Authors:  Yunlu Liu; Hongtao Tian; Yuxiang Hu; Yulin Cao; Hui Song; Shenghui Lan; Zhipeng Dai; Wei Chen; Yingze Zhang; Zengwu Shao; Yong Liu; Wei Tong
Journal:  Int J Biol Sci       Date:  2022-06-13       Impact factor: 10.750

Review 6.  YAP/TAZ in Bone and Cartilage Biology.

Authors:  Mylène Zarka; Eric Haÿ; Martine Cohen-Solal
Journal:  Front Cell Dev Biol       Date:  2022-01-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.